14 January 2021 - US pharmaceutical company Johnson & Johnson may submit an official application for approval of its COVID-19 vaccine to the EMA in February, according to European Health Commissioner Stella Kyriakides.
Johnson & Johnson’s vaccine would be the fourth, after that of Pfizer/BioNTech and Moderna (which are both already being administered) and AstraZeneca/Oxford (for which an application was submitted on Monday) that could be approved.